CUSIP No. 49705R 10 5 | 13G | Exhibit 99.1 |
JOINT FILING STATEMENT
We, the undersigned, hereby express our agreement that the attached statement on Schedule 13G relating to the Common Stock of Kinnate Biopharma Inc. is filed on behalf of each of us.
Dated: February 16, 2021
Nextech V Oncology S.C.S., SICAV-SIF
By: | Nextech V GP S.à r.l. |
Its: | General Partner |
By: | /s/ Dalia Bleyer | |
Dalia Bleyer, Managing Member | ||
By: | /s/ Thomas Lips | |
Thomas Lips, Managing Member |
Nextech V GP S.à r.l. | ||
By: | /s/ Dalia Bleyer | |
Dalia Bleyer, Managing Member | ||
By: | /s/ Thomas Lips | |
Thomas Lips, Managing Member |
/s/ Thomas Lips | |
Thomas Lips | |
/s/ Dalia Bleyer | |
Dalia Bleyer |